- Home
- CALC vs OPAD Comparison
CALC vs OPAD Comparison
Compare CALC & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- OPAD
- Stock Information
- Founded
- CALC 2011
- OPAD 2015
- Country
- CALC United States
- OPAD United States
- Employees
- CALC 15
- OPAD N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- CALC Health Care
- OPAD Finance
- Exchange
- CALC Nasdaq
- OPAD Nasdaq
- Market Cap
- CALC 45.4M
- OPAD 43.7M
- IPO Year
- CALC N/A
- OPAD N/A
- Fundamental
- Price
- CALC $3.23
- OPAD $2.85
- Analyst Decision
- CALC Strong Buy
- OPAD Hold
- Analyst Count
- CALC 2
- OPAD 5
- Target Price
- CALC $14.50
- OPAD $2.41
- AVG Volume (30 Days)
- CALC 52.6K
- OPAD 5.6M
- Earning Date
- CALC 11-12-2025
- OPAD 11-03-2025
- Dividend Yield
- CALC N/A
- OPAD N/A
- EPS Growth
- CALC N/A
- OPAD N/A
- EPS
- CALC N/A
- OPAD N/A
- Revenue
- CALC N/A
- OPAD $703,352,000.00
- Revenue This Year
- CALC N/A
- OPAD N/A
- Revenue Next Year
- CALC N/A
- OPAD $31.90
- P/E Ratio
- CALC N/A
- OPAD N/A
- Revenue Growth
- CALC N/A
- OPAD N/A
- 52 Week Low
- CALC $1.42
- OPAD $0.91
- 52 Week High
- CALC $5.65
- OPAD $6.35
- Technical
- Relative Strength Index (RSI)
- CALC 52.57
- OPAD 38.57
- Support Level
- CALC $3.13
- OPAD $2.75
- Resistance Level
- CALC $3.33
- OPAD $3.32
- Average True Range (ATR)
- CALC 0.20
- OPAD 0.42
- MACD
- CALC -0.00
- OPAD -0.17
- Stochastic Oscillator
- CALC 38.24
- OPAD 4.78
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.